Literature DB >> 6626456

Simultaneous micro measurement of steroid receptors in breast cancer.

G Milano, J L Moll, J L Formento, M Francoual, B P Krebs, M Namer, J L Boublil, C M Lalanne.   

Abstract

The oestradiol (RE) and progesterone (RP) receptor levels were analyzed in 26 tumour fragments (200-500 mg) from breast cancer patients. After pulverization of tissue, one part was analyzed by the routine dextran-coated charcoal (DCC) method and the other by a micromethod as follows: (i) cytosol incubation using the DCC method but in the simultaneous presence of [3H]oestradiol and [3H]R5020 (ii) extraction of the steroids bound to the receptor by precipitation with ethanol/TCA (iii) high pressure liquid chromatography (HPLC) on a modular system, with a C185 microns column and an elution by gradient mixture methanol/water. The fractions were collected and the radioactivity counted. The separation of oestradiol from R 5020 was rapid and complete. In addition dexamethasone was separated by this system making possible triple measures of RE, RP and glucocorticoid receptors. A highly significant correlation was obtained between the 2 methods: RE = 0.996, P less than 0.001; RP r = 0.975, P less than 0.001, implying that the thresholds of positivity, i.e. for therapeutic decisions, remain unchanged. Simultaneous measurement of RE and RP in a single needle biopsy is possible with this micromethod.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6626456      PMCID: PMC2011502          DOI: 10.1038/bjc.1983.231

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

1.  Results of treating stage III carcinoma of the breast by primary radiation therapy.

Authors:  J E Bruckman; J R Harris; M B Levene; J T Chaffey; S Hellman
Journal:  Cancer       Date:  1979-03       Impact factor: 6.860

Review 2.  Unique steroid congeners for receptor studies.

Authors:  T Ojasoo; J P Raynaud
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

3.  Estrogen receptors in human breast cancer.

Authors:  G Leclercq; J C Heuson; R Schoenfeld; W H Mattheiem; H J Tagnon
Journal:  Eur J Cancer       Date:  1973-09       Impact factor: 9.162

4.  Oestrogen-receptor determinations on fine-needle aspirations from malignant tumours of the breast.

Authors:  H S Poulsen; H Schultz; P Bichel
Journal:  Eur J Cancer       Date:  1979-12       Impact factor: 9.162

Review 5.  Steroid hormone receptors in breast cancer treatment strategy.

Authors:  W L McGuire
Journal:  Recent Prog Horm Res       Date:  1980

6.  Evaluation of estrogen receptor assays in human breast cancer tissue.

Authors:  W L McGuire; M De La Garza; G C Chamness
Journal:  Cancer Res       Date:  1977-03       Impact factor: 12.701

7.  Characterization and assay of progesterone receptor in human mammary carcinoma.

Authors:  M F Pichon; E Milgrom
Journal:  Cancer Res       Date:  1977-02       Impact factor: 12.701

8.  Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.

Authors:  J C Allegra; M E Lippman; E B Thompson; R Simon; A Barlock; L Green; K K Huff; H M Do; S C Aitken
Journal:  Cancer Res       Date:  1979-05       Impact factor: 12.701

Review 9.  The use of steroïd hormone receptors in the treatment of human breast cancer: a review.

Authors:  C K Osborne; W L McGuire
Journal:  Bull Cancer       Date:  1979       Impact factor: 1.276

10.  Reproducibility of measurements of oestrogen-receptor concentration in breast cancer.

Authors:  R A Hawkins; A Hill; B Freedman; S M Gore; M M Roberts; A P Forrest
Journal:  Br J Cancer       Date:  1977-09       Impact factor: 7.640

View more
  5 in total

1.  Epidermal growth factor receptor assay: validation of a single point method and application to breast cancer.

Authors:  J L Formento; M Francoual; P Formento; M C Etienne; J L Fischel; M Namer; M Frenay; E François; G Milano
Journal:  Breast Cancer Res Treat       Date:  1991 Jan-Feb       Impact factor: 4.872

2.  Pharmacoclinical data on high dose medroxyprogesterone acetate in advanced breast cancer.

Authors:  M Namer; G Milano; R Khater; M Frenay; A Thyss; N Renée
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

3.  Prognostic factors in 1,038 women with metastatic breast cancer.

Authors:  R Largillier; J-M Ferrero; J Doyen; J Barriere; M Namer; V Mari; A Courdi; J M Hannoun-Levi; F Ettore; I Birtwisle-Peyrottes; C Balu-Maestro; P Y Marcy; I Raoust; M Lallement; E Chamorey
Journal:  Ann Oncol       Date:  2008-07-17       Impact factor: 32.976

4.  Tamoxifen metabolism: pharmacokinetic and in vitro study.

Authors:  M C Etienne; G Milano; J L Fischel; M Frenay; E François; J L Formento; J Gioanni; M Namer
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

5.  Optimised analysis of tamoxifen and its main metabolites in the plasma and cytosol of mammary tumours.

Authors:  G Milano; M C Etienne; M Frenay; R Khater; J L Formento; N Renee; J L Moll; M Francoual; M Berto; M Namer
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.